middle.news
Orthocell Secures U.S. Defence Network Approval for Remplir™
9:08am on Wednesday 15th of April, 2026 AEST
•
Healthcare
Read Story
Orthocell Secures U.S. Defence Network Approval for Remplir™
9:08am on Wednesday 15th of April, 2026 AEST
Key Points
Remplir™ approved for 51 DoD and 170 VA hospitals in the U.S.
Orthocell leverages existing distributor network covering 17 states
Device validated in 23 surgical procedures on injured soldiers in Ukraine
Approval expands Orthocell’s access to key military and veteran healthcare markets
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Orthocell (ASX:OCC)
OPEN ARTICLE